Boxer Capital as of June 30, 2017
Portfolio Holdings for Boxer Capital
Boxer Capital holds 27 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 15.6 | $66M | 800k | 82.16 | |
| Clovis Oncology | 11.1 | $47M | 500k | 93.63 | |
| Esperion Therapeutics (ESPR) | 11.0 | $46M | 1.0M | 46.28 | |
| Medicines Company | 11.0 | $46M | 1.2M | 38.01 | |
| Macrogenics (MGNX) | 8.8 | $37M | 2.1M | 17.51 | |
| Ptc Therapeutics I (PTCT) | 7.4 | $31M | 1.7M | 18.33 | |
| Beigene (BGNE) | 6.4 | $27M | 600k | 45.00 | |
| Medicines | 4.8 | $20M | 531k | 38.01 | |
| Blueprint Medicines (BPMC) | 3.0 | $13M | 250k | 50.67 | |
| Incyte Corporation (INCY) | 3.0 | $13M | 100k | 125.91 | |
| G1 Therapeutics (GTHX) | 2.6 | $11M | 629k | 17.44 | |
| Puma Biotechnology (PBYI) | 2.1 | $8.7M | 100k | 87.40 | |
| La Jolla Pharmaceuticl Com Par | 1.9 | $8.0M | 268k | 29.77 | |
| Aquinox Pharmaceuticals | 1.8 | $7.4M | 525k | 14.07 | |
| Strongbridge Bioph shs usd | 1.6 | $6.7M | 940k | 7.15 | |
| Seattle Genetics | 1.5 | $6.5M | 125k | 51.74 | |
| Kura Oncology (KURA) | 1.2 | $5.0M | 533k | 9.30 | |
| Mirati Therapeutics | 0.9 | $3.8M | 1.0M | 3.65 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $3.3M | 234k | 13.97 | |
| Ipath S&p 500 Vix Short-term Futures Etn | 0.8 | $3.2M | 250k | 12.76 | |
| Sunesis Pharmaceuticals Inc Ne | 0.7 | $2.8M | 1.0M | 2.70 | |
| Bellerophon Therapeutics | 0.6 | $2.5M | 1.9M | 1.34 | |
| Cymabay Therapeutics | 0.6 | $2.4M | 425k | 5.76 | |
| Nabriva Therapeutics | 0.4 | $1.9M | 177k | 10.48 | |
| Eiger Biopharmaceuticals | 0.3 | $1.1M | 138k | 7.90 | |
| Onconova Therapeutics | 0.2 | $654k | 303k | 2.16 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $109k | 242k | 0.45 |
